AEONNN How It Works Pillars Membership FAQ Journal AEONNNian Access Request Early Access

Cellular Energy Over Time: How Mitochondrial Needs Evolve

What changes across decades is not mainly the number of mitochondria but the quality control that removes damaged ones. That shifts what a Pillar 1 protocol should target.

7 min read

The Short Answer

The intuitive model of mitochondrial ageing is that you lose mitochondria, so the response is to make more. The data suggest something more specific. Mitochondrial content declines modestly with age and largely in proportion to reduced physical activity, while the machinery that removes damaged mitochondria, mitophagy, declines more substantially and less reversibly. Quality control rather than quantity is what changes, and that shifts what a protocol should aim at across decades.

What Actually Changes With Age

Mitochondrial DNA damage accumulates. Mitochondrial DNA lacks the repair capacity of nuclear DNA and sits close to the source of reactive oxygen species. Deletions and point mutations accumulate, and because each cell contains many copies, a mixed population develops in which some mitochondria carry damage.

Mitophagy declines. The selective autophagy that identifies and removes damaged mitochondria becomes less efficient. This is arguably the central change, because it allows damaged mitochondria to persist and contribute to reactive oxygen species production and inflammatory signalling.

Biogenesis signalling weakens. PGC-1alpha expression and the responsiveness of the biogenesis pathway decline, which means the same training stimulus produces a somewhat smaller adaptation.

Network dynamics shift. The fusion and fission balance that allows mitochondria to share components and segregate damage changes with age.

Content declines modestly, and much of the observed decline in cross-sectional studies tracks reduced physical activity rather than age itself. Trained older adults retain considerably more mitochondrial capacity than untrained younger ones.

That last point is the most useful one in this article. A substantial part of what looks like mitochondrial ageing is deconditioning, and deconditioning is addressable.

Twenties and Thirties: Build the Ceiling

Mitochondrial capacity is near its peak and highly responsive to training, and the decisions made here set the level from which later decline occurs.

The priority is establishing aerobic capacity and muscle mass, because both decline from a starting point rather than from zero. A person who reaches 35 with high cardiorespiratory fitness and good muscle mass has a materially different trajectory from one who does not, and no later intervention recovers the difference fully.

What matters: consistent aerobic volume, resistance training, sleep sufficiency, and avoiding the metabolic drift that begins quietly in this decade. What does not matter much: mitochondrial supplements, in the absence of a specific shortfall. Cofactor adequacy is usually met by an adequate diet at this stage.

The most common error is using this decade as a period when fitness can be deferred. Aerobic capacity built here is the ceiling everything later is measured against.

Forties and Fifties: Defend Against Drift

Two changes converge. Metabolic drift becomes common, with rising fasting insulin, visceral adiposity and triglycerides, and this impairs mitochondrial function directly through lipid accumulation in muscle and liver. And training volume typically falls for reasons of time rather than capacity.

The priority shifts to defending metabolic health, because insulin resistance is the dominant modifiable threat to Pillar 1 in these decades.

What matters: maintaining aerobic volume rather than only intensity, resistance training becoming non-negotiable as muscle loss begins, glycaemic control, and addressing sleep-disordered breathing, whose prevalence rises here and which impairs mitochondrial function through intermittent hypoxia.

Where compounds enter: CoQ10 becomes more relevant, particularly if a statin is started, since statins reduce endogenous synthesis. Cofactor adequacy is worth verifying rather than assuming, as intake patterns change.

The practical marker to watch is heart rate at a fixed submaximal workload. It is sensitive to the drift described here and it responds to the correction.

Sixties and Beyond: Protect Function

ChangePriority response
Accelerating muscle lossResistance training and 1.2 to 1.6 g protein per kg body weight; this becomes the dominant priority
Reduced mitophagyExercise remains the main available stimulus; urolithin A targets this mechanism and is early
Blunted biogenesis responseMore consistency rather than more intensity; the same stimulus yields less, so regularity matters more
Reduced recovery capacityLonger intervals between hard sessions; overreaching is more costly
Higher medication loadInteraction and nutrient depletion checks become routine
Fall and frailty riskBalance and power work, not only endurance

The important inversion in these decades is that muscle preservation outranks metabolic optimisation. Interventions that reduce energy availability or lean mass, aggressive restriction among them, become net harmful even where their metabolic markers look favourable. Sarcopenia predicts function, independence and mortality, and a favourable HbA1c achieved at the cost of muscle is not a gain.

Reassessment Triggers

Signals that a Pillar 1 approach needs revisiting, regardless of age:

Heart rate rising at your usual workload over weeks. The most sensitive early signal, and it precedes subjective change.

Recovery taking longer after sessions that were previously routine.

Fatigue that does not respond to rest. This is a prompt for the standard panel, not for a stack adjustment.

A new statin. CoQ10 becomes worth considering.

Any new medication, for interaction and nutrient depletion.

Training volume having fallen without you noticing, which is the most common and least dramatic cause of declining capacity.

Weight loss, particularly rapid or medication-assisted, where lean mass is at risk.

A reasonable cadence: quarterly review of the functional markers, annual review of whether the protocol matches the current decade's priorities, and immediate review on any of the triggers above.

The Continuity Argument

Pillar 1 makes the case for continuity better than any other Pillar, because the same intervention has different value at different times and the drift is slow enough to be invisible without a record.

Aerobic volume in your thirties is building a ceiling. In your fifties it is defending against metabolic drift. In your seventies it is preserving the capacity that determines whether you can climb stairs. The prescription looks similar and the reason changes, and the balance against competing priorities changes with it.

The decline is also gradual enough that a person can lose a great deal of capacity without a single noticeable event. Heart rate at a fixed workload drifting upward by a few beats per year produces a large cumulative change and no memorable moment. A multi-year record catches this; memory does not.

That is the argument for measuring the same simple things consistently over decades rather than measuring elaborate things occasionally. The instrument matters less than the continuity of the record.

The AEONNN Perspective

This is Shield reasoning in its clearest form. A Pillar 1 protocol that does not change across decades is progressively less well matched, because the threat changes: building capacity in early adulthood, defending against metabolic drift in midlife, and preserving muscle and function later.

The Population layer supplies the age-dependence, and the most consequential item in it is the inversion in later decades. Interventions that reduce lean mass become net harmful even with favourable metabolic markers, which means a recommendation appropriate at 40 can be wrong at 75. Pillar 1 and Pillar 7 are coupled tightly enough that AEONNN handles them together in those decades.

The Real-Time User layer carries the signal that makes drift visible: heart rate at a fixed submaximal workload, read over years. The platform's emphasis on continuity is not a stylistic preference here, it is the only way a change of a few beats per year becomes legible before it becomes a limitation.

Database Matrix layers

  • Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
  • Mechanistic Layer (KEGG, Reactome, UniProt)
  • Population Layer (UK Biobank, NHANES)
  • Real-Time User Layer (wearable and adherence signals)

Frequently Asked

What changes in mitochondria with age?

Mitochondrial DNA damage accumulates and mitophagy declines, so damaged mitochondria persist. Content declines modestly and much of that tracks reduced physical activity rather than age itself.

Is mitochondrial decline reversible?

Partly. Trained older adults retain considerably more mitochondrial capacity than untrained younger ones, which means a substantial part of apparent mitochondrial ageing is deconditioning.

What matters most in your thirties?

Building aerobic capacity and muscle mass, because both later decline from a starting point. Capacity built here is the ceiling everything later is measured against.

What matters most in your fifties?

Defending metabolic health. Insulin resistance impairs mitochondrial function directly through lipid accumulation in muscle and liver, and it is the dominant modifiable threat in these decades.

What changes after sixty?

Muscle preservation outranks metabolic optimisation. Interventions that reduce lean mass become net harmful even with favourable markers, because sarcopenia predicts function and mortality.

What is the earliest sign of declining capacity?

Heart rate rising at your usual workload over weeks. It is more sensitive than subjective fatigue and it precedes noticeable change.

How often should I reassess?

Quarterly for functional markers, annually for whether the protocol matches your current decade, and immediately on a new medication, unexplained fatigue or unintended weight loss.

Evidence and review

Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.

Continue Reading

Membership

Reading about cellular Energy and Repair is not the same as knowing where you stand.

AEONNN organizes an article like this one against your own profile. Origin works through Discovered Mode, building your Pillar Matrix from the context you provide. Evolution adds Synched Mode, so supported wearable, Apple Health and laboratory data inform the same reasoning.

AEONNN turns knowledge like this into a protocol that is yours.

Private Early Access opens in August. Public launch follows in September.

By requesting access, you agree to receive AEONNN launch and membership communications. You may unsubscribe at any time. Privacy Policy · Consumer Health Data Privacy Notice

Back to the Journal →